Pricing Log in Create free account
Friday 6 November 2026 Export ITGR’s income statement to Excel — free account

Integer Holdings Corporation

ITGR Healthcare Medical Devices

Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.

Revenue
−3.86%
EPS
−61.0%
Free cash flow
−65.2%
Total debt
+4.06%

Quarter to September 2026, against a year earlier

126.54 0.21 −0.17%
Market cap
$4.3B
P/E
42.2×
Fwd P/E
38.9×
Dividend yield
—
F-score
6/9
Altman Z
2.34
Beneish M
−2.30
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Integer Holdings Corporation (ITGR) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Integer Holdings Corporation (ITGR) trades at a price to free cash flow of 53.3×. Over the past ten years it has ranged from 0.0× (December 2016) to 258× (June 2023); the current reading is higher than 80% of that period. That is above the Medical Devices industry median of 28.8× and above the Healthcare sector median of 21.1×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 26.2× (41.91%)
FY2024 45.0× (23.39%)
FY2023 58.8× (2.30%)
FY2022 60.2× 111.09%
FY2021 28.5× 38.98%
FY2020 20.5× (8.38%)
FY2019 22.4× 13.09%
FY2018 19.8× 42.40%
FY2017 13.9× (27.77%)
FY2016 19.2× —

Quarterly newest first

Period Price to free cash flow Change
Sep 2026 53.2× 85.75%
Jun 2026 28.6× (6.15%)
Mar 2026 30.5× 16.63%
Dec 2025 26.2× (13.15%)
43 more quarters

Against its own ten years

Low 0.0× High 258×
Ten-year median 25.0×
Current reading's percentile 80

Price to free cash flow against peers

Company Price to free cash flow
HAE Haemonetics Corporation compare 18.1×
UFPT UFP Technologies, Inc. compare 37.5×
LIVN LivaNova PLC compare 38.0×
NEOG Neogen Corporation compare 51.0×
ITGR Integer Holdings Corporation 53.3×
TMDX TransMedics Group, Inc. compare 53.5×
TXG 10x Genomics compare 63.3×
AXGN AxoGen, Inc. compare 134×
IRTC iRhythm Holdings, Inc. compare 584×
Medical Devices industry median 28.8×
Healthcare sector median 21.1×
Market median 14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on ITGR